No Data
No Data
BioAffinity Technologies Implements Key Efficiency Measures For Its Flagship Product, CyPath Lung, Noninvasive Test For Detection Of Lung Cancer
Express News | BioAffinity Technologies Increases Efficiency of Cypath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
ASP Isotopes and BioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
BioAffinity Technologies Increases Efficiency of CyPath Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
Express News | BioAffinity Technologies Files for Resale of up to 3.0 Mln Shares of Common Stock by Selling Stockholders - SEC Filing
Trending Stocks Today | Innovation Beverage Group Shoots up 220.61% Pre-Market